Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 143

Similar articles for PubMed (Select 24161038)

1.

The role of complement in membranous nephropathy.

Ma H, Sandor DG, Beck LH Jr.

Semin Nephrol. 2013 Nov;33(6):531-42. doi: 10.1016/j.semnephrol.2013.08.004. Review.

2.

M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.

Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ.

N Engl J Med. 2009 Jul 2;361(1):11-21. doi: 10.1056/NEJMoa0810457.

3.

Recurrent membranous nephropathy in an allograft caused by IgG3╬║ targeting the PLA2 receptor.

Debiec H, Hanoy M, Francois A, Guerrot D, Ferlicot S, Johanet C, Aucouturier P, Godin M, Ronco P.

J Am Soc Nephrol. 2012 Dec;23(12):1949-54. doi: 10.1681/ASN.2012060577. Epub 2012 Nov 2.

4.

Membranous nephropathy: recent travels and new roads ahead.

Beck LH Jr, Salant DJ.

Kidney Int. 2010 May;77(9):765-70. doi: 10.1038/ki.2010.34. Epub 2010 Feb 24. Review.

PMID:
20182413
5.

Pathogenesis of membranous nephropathy: update.

Kwatra IS, Prasher PK.

J Assoc Physicians India. 2013 Nov;61(11):807-10. Review.

PMID:
24974493
6.

Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.

Hoxha E, Knei├čler U, Stege G, Zahner G, Thiele I, Panzer U, Harendza S, Helmchen UM, Stahl RA.

Kidney Int. 2012 Oct;82(7):797-804. doi: 10.1038/ki.2012.209. Epub 2012 Jun 6.

PMID:
22673885
7.

IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression.

Huang CC, Lehman A, Albawardi A, Satoskar A, Brodsky S, Nadasdy G, Hebert L, Rovin B, Nadasdy T.

Mod Pathol. 2013 Jun;26(6):799-805. doi: 10.1038/modpathol.2012.237. Epub 2013 Jan 18.

8.

Pathogenesis of membranous nephropathy: a new paradigm in evolution.

Glassock RJ.

Contrib Nephrol. 2013;181:131-42. doi: 10.1159/000348472. Epub 2013 May 8. Review.

PMID:
23689575
9.

IgG subclasses and complement pathway in segmental and global membranous nephropathy.

Segawa Y, Hisano S, Matsushita M, Fujita T, Hirose S, Takeshita M, Iwasaki H.

Pediatr Nephrol. 2010 Jun;25(6):1091-9. doi: 10.1007/s00467-009-1439-8. Epub 2010 Feb 12.

PMID:
20151159
10.

Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy.

Kao L, Lam V, Waldman M, Glassock RJ, Zhu Q.

J Am Soc Nephrol. 2015 Feb;26(2):291-301. doi: 10.1681/ASN.2013121315. Epub 2014 Sep 9.

PMID:
25205735
11.

Podocyte antigens and glomerular disease.

Ronco P, Debiec H.

Nephron Exp Nephrol. 2007;107(2):e41-6. Epub 2007 Aug 27. Review.

PMID:
17726340
12.

Cellular response to injury in membranous nephropathy.

Nangaku M, Shankland SJ, Couser WG.

J Am Soc Nephrol. 2005 May;16(5):1195-204. Epub 2005 Mar 30. Review.

13.

The pathogenesis of membranous nephropathy: evolution and revolution.

Glassock RJ.

Curr Opin Nephrol Hypertens. 2012 May;21(3):235-42. doi: 10.1097/MNH.0b013e3283522ea8. Review.

PMID:
22388552
14.

Contrasting roles of complement activation and its regulation in membranous nephropathy.

Cunningham PN, Quigg RJ.

J Am Soc Nephrol. 2005 May;16(5):1214-22. Epub 2005 Mar 30. Review.

15.

Antigen identification in membranous nephropathy moves toward targeted monitoring and new therapy.

Ronco P, Debiec H.

J Am Soc Nephrol. 2010 Apr;21(4):564-9. doi: 10.1681/ASN.2009121220. Epub 2010 Feb 25.

16.

Membranous nephropathy: from models to man.

Beck LH Jr, Salant DJ.

J Clin Invest. 2014 Jun;124(6):2307-14. doi: 10.1172/JCI72270. Epub 2014 Jun 2. Review.

17.

Membranous nephropathy.

Cybulsky AV.

Contrib Nephrol. 2011;169:107-25. doi: 10.1159/000313948. Epub 2011 Jan 20. Review.

PMID:
21252514
18.

Detection of anti-PLA2R autoantibodies and IgG subclasses in post-allogeneic hematopoietic stem cell transplantation membranous nephropathy.

Huang X, Qin W, Zhang M, Zheng C, Zeng C, Liu Z.

Am J Med Sci. 2013 Jul;346(1):32-7. doi: 10.1097/MAJ.0b013e318267b5cd.

PMID:
23103439
19.

PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy.

Debiec H, Ronco P.

N Engl J Med. 2011 Feb 17;364(7):689-90. doi: 10.1056/NEJMc1011678. No abstract available.

20.

Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy.

Hoxha E, Thiele I, Zahner G, Panzer U, Harendza S, Stahl RA.

J Am Soc Nephrol. 2014 Jun;25(6):1357-66. doi: 10.1681/ASN.2013040430. Epub 2014 Mar 7.

PMID:
24610926
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk